RxDoctor Payments Data

Brittany Harrison

Family · Evansville, INNPI 1164783387

Payments from drug & device makers

$2,597in general payments, 2019–2025

Across 144 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$784
  • Abbott$403
  • Amgen$192
  • Biohaven Pharmaceutical Holding Company Ltd.$161
  • Pfizer$158
  • Scilex Pharmaceuticals Inc.$114
  • plus $784 from 14 others

What the payments were for

  • Food & beverage$2,597100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,597 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$78,865
Medicare patients
171
Services billed
938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen776$20,781
BelbucaBuprenorphine Hcl25$18,778
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen660$16,629
LyricaPregabalin11$9,997
Buprenorphine29$8,153
MovantikNaloxegol Oxalate16$6,316
Gabapentin481$5,618
Lidocaine50$4,587
Pregabalin149$3,315
Oxycodone Hcl53$1,856
Cyclobenzaprine Hcl197$1,790
Tizanidine Hcl157$1,755
Morphine Sulfate ErMorphine Sulfate30$1,686
Fentanyl16$1,655
Hydromorphone Hcl68$1,440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$67$18,77825 claims
PfizerLyrica$158$9,99711 claims
Redhill Biopharma Inc.Movantik$46$6,31616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.

Other family in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →